Arthritis and Diabetes Clinic

Monroe, Louisiana 71203

0 studies enrolling now · 13 studies all time

What they study most

Acute Gout, Arthritis, Chronic Kidney Disease (CKD), Diabetes Mellitus, Type 2, Gout, Low Back Pain, Lupus Erythematosus, Systemic, Osteoarthritis, Osteoarthritis, Hip, Renal Insufficiency, Rheumatoid Arthritis

Studies at this site

• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
• A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment — Stopped early
• A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
• Effects of Abatacept in Patients With Early Rheumatoid Arthritis — Completed
• Extension Study Of Tanezumab In Osteoarthritis — Stopped early
• Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
• Tanezumab in Osteoarthritis of the Knee — Completed
• Tanezumab in Osteoarthritis Of The Hip — Completed
• Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study) — Completed
• Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency — Completed
• Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis — Completed
• Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study. — Completed
• Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients — Completed